BCL2 and B-cell non-Hodgkin lymphoma: This had been used to argue for the classification of rare cases of TdT‐positive blastoid B‐cell lymphoma with both MYC and BCL2 translocations as B‐LBL in the revised fourth edition of the World Health Organization classification of haematolymphoid tumours (WHO‐HAEM4R) [2].